(Q39559533)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

main subject

gram-positive bacteria

0 references

Gram-negative bacteria

0 references

author name string

G A Pankuch

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M R Jacobs

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P C Appelbaum

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

3028-3031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms.

6 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Post-antibiotic effects of RP 59500 with Staphylococcus aureus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Post-antibiotic effect of the new streptogramin RP 59500.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105989

Kinetics of antimicrobial activity

21 August 2018

1 reference

12 December 2020

A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500

1 reference

12 December 2020

The postantibiotic effect of RP 59500 on Staphylococcus aureus including strains with a raised MBC

1 reference

12 December 2020

Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp

1 reference

12 December 2020

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.42.11.3028

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9797249%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

PubMed publication ID

9797249

1 reference